Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 6Neoplasms 3Melanoma 3Glioma 3Stomach Neoplasms 2Glioblastoma 2Breast Neoplasms 2Thyroid Diseases 1Skin Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Paget Disease, Extramammary 1Ovarian Neoplasms 1Neuroma, Acoustic 1Lung Neoplasms 1Laryngeal Neoplasms 1Irritable Bowel Syndrome 1Gastrointestinal Stromal Tumors 1Gastrointestinal Diseases 1Gastroesophageal Reflux 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Cerebrovascular Disorders 1Carcinoma, Hepatocellular 1Barrett Esophagus 1Astrocytoma 1Adenomatous Polyps 1Adenolymphoma 1

Interventions

Surveys and Questionnaires 1Phlebotomy 1Neoadjuvant Therapy 1Lysine Acetyltransferase 5 1GSK3352589 1Fluorescein 1Colonoscopy 1Chemoradiotherapy 1Cathartics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Irritable Bowel Syndrome × Fluorescein × Clear all
NCT03220711 2022-11-22

Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon

University of Michigan

Phase NA Terminated
72 enrolled

Adenomatous Polyps, Irritable Bowel Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡